ALEC — Alector, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1653087 ·
Last close
$2.56
Market Cap
$381.13M
52W High
$2.84
52W Low
$1.09
ADV30
2,378,964
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 162,866,000 | — | 123,841,000 | 124,600,000 | 165,777,000 | 75,472,000 | 49,208,000 |
| Jun 2026 | 3,320,000 | — | -24,393,000 | -22,990,000 | 202,855,000 | 59,915,000 | 212,825,000 |
| Mar 2026 | 1,046,000 | — | -24,919,000 | -22,930,000 | 239,916,000 | 76,962,000 | 229,534,000 |
| Dec 2025 | 6,237,000 | — | -39,566,000 | -37,267,000 | 293,237,000 | 65,802,000 | 262,588,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-158,232,000
Investing CF
$153,208,000
Financing CF
$20,168,000
CapEx
$-170,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.10
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,017,976,000
Inventory
—
Receivables
—
ST Investments
$112,883,000
EBIT TTM
$-126,486,000
Pretax Income TTM
$-117,556,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$173,468,992
EBITDA
$42,164,000
Free Cash Flow
$16,585,125
Enterprise Value
$223,231,504
Total Cash
$138,696,992
Total Debt
$21,000,000
Shares Out
148,877,074
Trailing EPS
$0.37
Book Value
$1.04
ROE
47.5%
ROA
9.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 21,045,000 | -156,007,000 | -142,929,000 | 293,237,000 | 262,588,000 | 30,649,000 | -184,031,000 |
| Dec 2024 | 100,558,000 | -144,997,000 | -119,049,000 | 468,303,000 | 341,503,000 | 126,800,000 | -229,905,000 |
| Dec 2023 | 97,062,000 | -151,740,000 | -130,391,000 | 621,827,000 | 487,669,000 | 134,158,000 | -184,162,000 |
| Dec 2022 | 133,617,000 | -137,834,000 | -133,310,000 | 787,648,000 | 573,206,000 | 214,442,000 | -20,329,000 |
TTM Snapshot
Revenues TTM
$13,863,000
NetIncome TTM
$-117,854,000
OpCashFlow TTM
—
Assets (Latest)
$202,855,000
Forward EPS
$-0.71
Max Pain — expiry 2027-01-15
max pain strike: $2.50 · spot: $2.57 · call oi: 1,347 · put oi: 40,788
Expected Move to 2027-01-15:
±$0.75
(29.18%) —
implied range
$1.82 –
$3.32
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TECX | Tectonic Therapeutic, Inc. | $392.55M | $20.08 | — |
| SLBT | SL Science Holding Ltd | $356.14M | $0.64 | — |
| IRLA | IRulya Therapeutics Inc. | $416.85M | $38.45 | — |
| JSPR | Jasper Therapeutics, Inc. | $344.06M | $10.34 | — |
| CADL | Candel Therapeutics, Inc. | $423.61M | $5.40 | — |
News headlines (Yahoo Finance, 1h cache)
Alector (ALEC) Stock Sees Fair Value Lift As Analysts Split On Genentech Deal
2026-11-16 23:20 · Yahoo
Are Medical Stocks Lagging Alector (ALEC) This Year?
2026-11-11 20:07 · Yahoo
Earnings Estimates Rising for Alector (ALEC): Will It Gain?
2026-11-11 16:20 · Yahoo
Alector: Q3 Earnings Snapshot
2026-11-05 23:58 · Yahoo
Alector Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-05 21:05 · Yahoo
What Alector Shareholders Got Right
2026-11-03 05:10 · Yahoo
Will Alector (ALEC) Report Negative Q3 Earnings? What You Should Know
2026-10-29 13:00 · Yahoo
Alector stock surges 13% on premium-priced equity offering
2026-10-16 13:26 · Yahoo
Alector Announces Pricing of Underwritten Offering
2026-10-16 11:30 · Yahoo
Alector (ALEC) Stock Fair Value Rises After Genentech Deal Draws Split Analyst Views
2026-10-16 00:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.